Paul Brown, M.D., has manuscript recognized as most notable by Alliance for Clinical Trials in Oncology
Paul Brown, M.D. (I-1 ’96, RADO ’00), Department of Radiation Oncology at Mayo Clinic in Rochester, had a manuscript recognized as most notable of 2016-2017 by the Alliance for Clinical Trials in Oncology. His manuscript was “Postoperative Stereotactic Radiosurgery Compared with Whole Brain Radiotherapy for Resected Metastatic Brain Disease (NCCTG N107C/CEC.3): A Multicentre, Randomised, Controlled, Phase 3 Trial,” and it was published in Lancet Oncology in 2017.
Selection of the most significant manuscripts is based on review by the alliance’s scientific leadership and a separate review panel. Each nominated manuscript must satisfy at least one of the following criteria: potential to change the standard of care; potential to change the way clinical trials are designed and/or executed; and potential to change understanding of cancer biology.
Dr. Brown is a professor of radiation oncology in the Mayo Clinic College of Medicine and Science.